Use of Aripiprazole for Agitation in Cardiomyopathy Patients

Safety Profile and Alternative Options

• Aripiprazole can be used as a PRN medication for agitation in patients with cardiomyopathy as it has not been associated with QTc prolongation or torsades de pointes, making it a safer option compared to other antipsychotics in patients with cardiac conditions 1
• Unlike other antipsychotics, aripiprazole has not been associated with QTc prolongation or torsades de pointes, making it a safer choice for patients with cardiomyopathy 1
• If aripiprazole is not effective or contraindicated, benzodiazepines may provide a safer cardiovascular alternative in patients with severe left ventricular dysfunction or heart failure 1, 2
• Opiates may be beneficial in patients with malignant ventricular arrhythmias due to their anti-arrhythmic effects via stimulation of kappa receptors 1
• Avoid conventional antipsychotics like haloperidol in patients with cardiomyopathy due to higher risk of QTc prolongation and torsades de pointes 1